![NLI NLI](https://data.pdbj.org/pdbjplus/data/cc/svg/NLI.svg) | NLI | Name: | N-[2-(carbamimidamidooxy)ethyl]-2-{3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxopyrazin-1(2H)-yl}acetamide | Formula: | C18 H23 F2 N7 O3 | SMILES: | O=C(NCCONC(=[N@H])N)CN1C(=CN=C(C1=O)NCC(F)(F)c2ccccc2)C | InChi: | InChI=1S/C18H23F2N7O3/c1-12-9-24-15(25-11-18(19,20)13-5-3-2-4-6-13)16(29)27(12)10-14(28)23-7-8-30-26-17(21)22/h2-6,9H,7-8,10-11H2,1H3,(H,23,28)(H,24,25)(H4,21,22,26) | Synonyms: | RWJ-671818 | Definition date: | 2010-04-15 | Last modified: | 2021-03-01 | Identifier: | N-[2-(carbamimidamidooxy)ethyl]-2-{3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxopyrazin-1(2H)-yl}acetamide |
|
![NLN NLN](https://data.pdbj.org/pdbjplus/data/cc/svg/NLN.svg) | NLN | Name: | NORLEUCINE AMIDE | Formula: | C6 H14 N2 O | SMILES: | O=C(N)C(N)CCCC | InChi: | InChI=1S/C6H14N2O/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H2,8,9)/t5-/m0/s1 | Synonyms: | 2-AMINO-HEXANOIC ACID AMIDE | Definition date: | 2000-02-02 | Last modified: | 2021-03-01 | Identifier: | L-norleucinamide |
|
![NLP NLP](https://data.pdbj.org/pdbjplus/data/cc/svg/NLP.svg) | NLP | Name: | (1-AMINO-PENTYL)-PHOSPHONIC ACID | Formula: | C5 H14 N O3 P | SMILES: | O=P(O)(O)C(N)CCCC | InChi: | InChI=1S/C5H14NO3P/c1-2-3-4-5(6)10(7,8)9/h5H,2-4,6H2,1H3,(H2,7,8,9)/t5-/m1/s1 | Synonyms: | NORLEUCINE PHOSPHONATE | Definition date: | 1999-07-28 | Last modified: | 2021-03-01 | Identifier: | [(1R)-1-aminopentyl]phosphonic acid |
|
![NLX NLX](https://data.pdbj.org/pdbjplus/data/cc/svg/NLX.svg) | NLX | Name: | (5A,17R)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-17-(2-PROPENYL)-MORPHINANIUM | Formula: | C20 H24 N O4 | SMILES: | O=C5C3Oc1c2c(ccc1O)CC4C(O)(C23CC[N+]4(C)C/C=C)CC5 | InChi: | InChI=1S/C20H23NO4/c1-3-9-21(2)10-8-19-16-12-4-5-13(22)17(16)25-18(19)14(23)6-7-20(19,24)15(21)11-12/h3-5,15,18,24H,1,6-11H2,2H3/p+1/t15-,18+,19+,20-,21-/m1/s1 | Synonyms: | N-METHYLNALOXONIUM | Definition date: | 2002-10-24 | Last modified: | 2021-03-01 | Identifier: | (5alpha,17S)-3,14-dihydroxy-17-methyl-6-oxo-17-(prop-2-en-1-yl)-4,5-epoxymorphinan-17-ium |
|
![NM1 NM1](https://data.pdbj.org/pdbjplus/data/cc/svg/NM1.svg) | NM1 | Name: | 3-(7-BENZYL-4,5-DIHYDROXY-1,1-DIOXO-3,6-BIS-PHENOXYMETHYL-1L6-[1,2,7]THIADIAZEPAN-2-YLMETHYL)-N-METHYL-BENZAMIDE | Formula: | C34 H37 N3 O7 S | SMILES: | O=S2(=O)N(C(C(O)C(O)C(N2Cc1cc(C(=O)NC)ccc1)COc3ccccc3)COc4ccccc4)Cc5ccccc5 | InChi: | InChI=1S/C34H37N3O7S/c1-35-34(40)27-15-11-14-26(20-27)22-37-31(24-44-29-18-9-4-10-19-29)33(39)32(38)30(23-43-28-16-7-3-8-17-28)36(45(37,41)42)21-25-12-5-2-6-13-25/h2-20,30-33,38-39H,21-24H2,1H3,(H,35,40)/t30-,31-,32+,33+/m1/s1 | Synonyms: | AHA047 | Definition date: | 2000-10-30 | Last modified: | 2021-03-01 | Identifier: | 3-{[(3R,4S,5S,6R)-7-benzyl-4,5-dihydroxy-1,1-dioxido-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl}-N-methylbenzamide |
|
![NMG NMG](https://data.pdbj.org/pdbjplus/data/cc/svg/NMG.svg) | NMG | Name: | GUANIDINO ACETATE | Formula: | C3 H7 N3 O2 | SMILES: | O=C(O)CNC(=[N@H])N | InChi: | InChI=1S/C3H7N3O2/c4-3(5)6-1-2(7)8/h1H2,(H,7,8)(H4,4,5,6) | Synonyms: | N-[AMINO(IMINO)METHYL]GLYCINE | Definition date: | 2004-09-21 | Last modified: | 2021-03-01 | Identifier: | N-carbamimidoylglycine |
|
![NND NND](https://data.pdbj.org/pdbjplus/data/cc/svg/NND.svg) | NND | Name: | (2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL | Formula: | C15 H31 N O4 | SMILES: | OCC1N(CCCCCCCCC)CC(O)C(O)C1O | InChi: | InChI=1S/C15H31NO4/c1-2-3-4-5-6-7-8-9-16-10-13(18)15(20)14(19)12(16)11-17/h12-15,17-20H,2-11H2,1H3/t12-,13+,14-,15-/m1/s1 | Synonyms: | N-NONYL-DEOXYNOJIRIMYCIN | Definition date: | 2007-06-18 | Last modified: | 2021-03-01 | Identifier: | (2R,3R,4R,5S)-2-(hydroxymethyl)-1-nonylpiperidine-3,4,5-triol |
|
![NOG NOG](https://data.pdbj.org/pdbjplus/data/cc/svg/NOG.svg) | NOG | Name: | 13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE | Formula: | C21 H28 O2 | SMILES: | O=C4C=C3C(C2CCC1(C(CCC1(C#C)O)C2CC3)CC)CC4 | InChi: | InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1 | Synonyms: | NORGESTREL | Definition date: | 2002-04-29 | Last modified: | 2021-03-01 | Identifier: | (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name) |
|
![NOJ NOJ](https://data.pdbj.org/pdbjplus/data/cc/svg/NOJ.svg) | NOJ | Name: | 1-DEOXYNOJIRIMYCIN | Formula: | C6 H13 N O4 | SMILES: | OC1C(NCC(O)C1O)CO | InChi: | InChI=1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5-,6-/m1/s1 | Synonyms: | MORANOLINE | Definition date: | 1999-07-08 | Last modified: | 2021-03-01 | Identifier: | (2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol |
|
![NOT NOT](https://data.pdbj.org/pdbjplus/data/cc/svg/NOT.svg) | NOT | Name: | 6-azido-L-norleucine | Formula: | C6 H12 N4 O2 | SMILES: | [N-]=[N+]=N/CCCCC(N)C(=O)O | InChi: | InChI=1S/C6H12N4O2/c7-5(6(11)12)3-1-2-4-9-10-8/h5H,1-4,7H2,(H,11,12)/t5-/m0/s1 | Synonyms: | AZIDONORLEUCINE | Definition date: | 2009-05-08 | Last modified: | 2021-03-01 | Identifier: | 6-azido-L-norleucine |
|
![RTJ RTJ](https://data.pdbj.org/pdbjplus/data/cc/svg/RTJ.svg) | RTJ | Name: | (7R)-8-(cyclopropylmethyl)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7-methyl-5-(prop-2-yn-1-yl)-7,8-dihydropteridin-6(5H)-one | Formula: | C20 H19 F2 N5 O2 | SMILES: | c4(F)c(O)c(cc(Nc1nc2c(cn1)N(CC#C)C(=O)C(C)N2CC3CC3)c4)F | InChi: | InChI=1S/C20H19F2N5O2/c1-3-6-26-16-9-23-20(24-13-7-14(21)17(28)15(22)8-13)25-18(16)27(10-12-4-5-12)11(2)19(26)29/h1,7-9,11-12,28H,4-6,10H2,2H3,(H,23,24,25)/t11-/m1/s1 | Definition date: | 2020-02-25 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | (7R)-8-(cyclopropylmethyl)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7-methyl-5-(prop-2-yn-1-yl)-7,8-dihydropteridin-6(5H)-one |
|
![RUE RUE](https://data.pdbj.org/pdbjplus/data/cc/svg/RUE.svg) | RUE | Name: | 3-[[(3-Carboxyphenyl)methyl-[2-(hydroxyamino)-2-oxoethyl]amino]methyl]benzoic acid | Formula: | C18 H18 N2 O6 | SMILES: | ONC(=O)CN(Cc1cccc(c1)C(O)=O)Cc2cccc(c2)C(O)=O | InChi: | InChI=1S/C18H18N2O6/c21-16(19-26)11-20(9-12-3-1-5-14(7-12)17(22)23)10-13-4-2-6-15(8-13)18(24)25/h1-8,26H,9-11H2,(H,19,21)(H,22,23)(H,24,25) | Synonyms: | 3-[[(3-carboxyphenyl)methyl-[2-(oxidanylamino)-2-oxidanylidene-ethyl]amino]methyl]benzoic acid | Definition date: | 2020-10-20 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | 3-[[(3-carboxyphenyl)methyl-[2-(oxidanylamino)-2-oxidanylidene-ethyl]amino]methyl]benzoic acid |
|
![T3W T3W](https://data.pdbj.org/pdbjplus/data/cc/svg/T3W.svg) | T3W | Name: | 2-(4-iodophenyl)-8~{H}-imidazo[1,2-c]pyrimidin-5-one | Formula: | C12 H8 I N3 O | SMILES: | Ic1ccc(cc1)c2cn3C(=O)N=CCc3n2 | InChi: | InChI=1S/C12H8IN3O/c13-9-3-1-8(2-4-9)10-7-16-11(15-10)5-6-14-12(16)17/h1-4,6-7H,5H2 | Definition date: | 2020-12-14 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | 2-(4-iodophenyl)-8~{H}-imidazo[1,2-c]pyrimidin-5-one |
|
![YD1 YD1](https://data.pdbj.org/pdbjplus/data/cc/svg/YD1.svg) | YD1 | Name: | 6-[4-(3,4-dichlorophenyl)piperazin-1-yl]carbonyl-1~{H}-pyrimidine-2,4-dione | Formula: | C15 H14 Cl2 N4 O3 | SMILES: | Clc1ccc(cc1Cl)N2CCN(CC2)C(=O)C3=CC(=O)NC(=O)N3 | InChi: | InChI=1S/C15H14Cl2N4O3/c16-10-2-1-9(7-11(10)17)20-3-5-21(6-4-20)14(23)12-8-13(22)19-15(24)18-12/h1-2,7-8H,3-6H2,(H2,18,19,22,24) | Definition date: | 2021-02-22 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | 6-[4-(3,4-dichlorophenyl)piperazin-1-yl]carbonyl-1~{H}-pyrimidine-2,4-dione |
|
![T4N T4N](https://data.pdbj.org/pdbjplus/data/cc/svg/T4N.svg) | T4N | Name: | ~{N}-(4-methoxyphenyl)-2-[(2~{S})-3-oxidanylidenethiomorpholin-2-yl]ethanamide | Formula: | C13 H16 N2 O3 S | SMILES: | COc1ccc(NC(=O)C[CH]2SCCNC2=O)cc1 | InChi: | InChI=1S/C13H16N2O3S/c1-18-10-4-2-9(3-5-10)15-12(16)8-11-13(17)14-6-7-19-11/h2-5,11H,6-8H2,1H3,(H,14,17)(H,15,16)/t11-/m0/s1 | Definition date: | 2020-12-14 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | ~{N}-(4-methoxyphenyl)-2-[(2~{S})-3-oxidanylidenethiomorpholin-2-yl]ethanamide |
|
![XEY XEY](https://data.pdbj.org/pdbjplus/data/cc/svg/XEY.svg) | XEY | Name: | 2-[3-(3,5-dichlorophenyl)-2-oxo[2H-[1,3'-bipyridine]]-5-yl]benzonitrile | Formula: | C23 H13 Cl2 N3 O | SMILES: | c1(cc(cc(c1)C4=CC(c2ccccc2C#N)=CN(c3cccnc3)C4=O)Cl)Cl | InChi: | InChI=1S/C23H13Cl2N3O/c24-18-8-16(9-19(25)11-18)22-10-17(21-6-2-1-4-15(21)12-26)14-28(23(22)29)20-5-3-7-27-13-20/h1-11,13-14H | Definition date: | 2020-12-15 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | 2-[3-(3,5-dichlorophenyl)-2-oxo[2H-[1,3'-bipyridine]]-5-yl]benzonitrile |
|
![XF1 XF1](https://data.pdbj.org/pdbjplus/data/cc/svg/XF1.svg) | XF1 | Name: | 2-[3-(3-chloro-5-propoxyphenyl)-2-oxo[2H-[1,3'-bipyridine]]-5-yl]benzonitrile | Formula: | C26 H20 Cl N3 O2 | SMILES: | C2=C(c1c(C#N)cccc1)C=C(C(=O)N2c3cccnc3)c4cc(cc(OCCC)c4)Cl | InChi: | InChI=1S/C26H20ClN3O2/c1-2-10-32-23-12-19(11-21(27)14-23)25-13-20(24-8-4-3-6-18(24)15-28)17-30(26(25)31)22-7-5-9-29-16-22/h3-9,11-14,16-17H,2,10H2,1H3 | Definition date: | 2020-12-15 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | 2-[3-(3-chloro-5-propoxyphenyl)-2-oxo[2H-[1,3'-bipyridine]]-5-yl]benzonitrile |
|
![XF4 XF4](https://data.pdbj.org/pdbjplus/data/cc/svg/XF4.svg) | XF4 | Name: | (5S)-5-{3-[3-(benzyloxy)-5-chlorophenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}pyrimidine-2,4(3H,5H)-dione | Formula: | C27 H19 Cl N4 O4 | SMILES: | C2(N(c1cnccc1)C=C(C=C2c3cc(cc(c3)OCc4ccccc4)Cl)C=5C(=O)NC(NC=5)=O)=O | InChi: | InChI=1S/C27H19ClN4O4/c28-20-9-18(10-22(12-20)36-16-17-5-2-1-3-6-17)23-11-19(24-14-30-27(35)31-25(24)33)15-32(26(23)34)21-7-4-8-29-13-21/h1-15H,16H2,(H2,30,31,33,35) | Definition date: | 2020-12-15 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | 5-{3-[3-(benzyloxy)-5-chlorophenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}pyrimidine-2,4(1H,3H)-dione |
|
![TJW TJW](https://data.pdbj.org/pdbjplus/data/cc/svg/TJW.svg) | TJW | Name: | 5-amino-N-(4-(((2S)-4-cyclohexyl-1-((1-(methylsulfonyl)piperidin-3-yl)amino)-1-oxobutan-2-yl)carbamoyl)benzyl)-1-phenyl-1H-pyrazole-4-carboxamide | Formula: | C34 H45 N7 O5 S | SMILES: | C[S](=O)(=O)N1CCC[CH](C1)NC(=O)[CH](CCC2CCCCC2)NC(=O)c3ccc(CNC(=O)c4cnn(c4N)c5ccccc5)cc3 | InChi: | InChI=1S/C34H45N7O5S/c1-47(45,46)40-20-8-11-27(23-40)38-34(44)30(19-16-24-9-4-2-5-10-24)39-32(42)26-17-14-25(15-18-26)21-36-33(43)29-22-37-41(31(29)35)28-12-6-3-7-13-28/h3,6-7,12-15,17-18,22,24,27,30H,2,4-5,8-11,16,19-21,23,35H2,1H3,(H,36,43)(H,38,44)(H,39,42)/t27-,30-/m0/s1 | Synonyms: | 5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-[[(3~{S})-1-methylsulfonylpiperidin-3-yl]amino]-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide | Definition date: | 2020-12-23 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | 5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-[[(3~{S})-1-methylsulfonylpiperidin-3-yl]amino]-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide |
|
![XF7 XF7](https://data.pdbj.org/pdbjplus/data/cc/svg/XF7.svg) | XF7 | Name: | (5S)-5-(3-{3-chloro-5-[(2-chlorophenyl)methoxy]phenyl}-2-oxo[2H-[1,3'-bipyridine]]-5-yl)pyrimidine-2,4(3H,5H)-dione | Formula: | C27 H18 Cl2 N4 O4 | SMILES: | C2(N(c1cnccc1)C=C(C=C2c3cc(cc(c3)OCc4ccccc4Cl)Cl)C=5C(=O)NC(=O)NC=5)=O | InChi: | InChI=1S/C27H18Cl2N4O4/c28-19-8-17(9-21(11-19)37-15-16-4-1-2-6-24(16)29)22-10-18(23-13-31-27(36)32-25(23)34)14-33(26(22)35)20-5-3-7-30-12-20/h1-14H,15H2,(H2,31,32,34,36) | Definition date: | 2020-12-15 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | 5-(3-{3-chloro-5-[(2-chlorophenyl)methoxy]phenyl}-2-oxo[2H-[1,3'-bipyridine]]-5-yl)pyrimidine-2,4(1H,3H)-dione |
|
![TJZ TJZ](https://data.pdbj.org/pdbjplus/data/cc/svg/TJZ.svg) | TJZ | Name: | ~{N}-[(2~{S})-4-cyclohexyl-1-[[(3~{R})-1-methylsulfonylpiperidin-3-yl]amino]-1-oxidanylidene-butan-2-yl]-4-[[(1-phenylpyrazolo[3,4-d]pyrimidin-4-yl)amino]methyl]benzamide | Formula: | C35 H44 N8 O4 S | SMILES: | C[S](=O)(=O)N1CCC[CH](C1)NC(=O)[CH](CCC2CCCCC2)NC(=O)c3ccc(CNc4ncnc5n(ncc45)c6ccccc6)cc3 | InChi: | InChI=1S/C35H44N8O4S/c1-48(46,47)42-20-8-11-28(23-42)40-35(45)31(19-16-25-9-4-2-5-10-25)41-34(44)27-17-14-26(15-18-27)21-36-32-30-22-39-43(33(30)38-24-37-32)29-12-6-3-7-13-29/h3,6-7,12-15,17-18,22,24-25,28,31H,2,4-5,8-11,16,19-21,23H2,1H3,(H,40,45)(H,41,44)(H,36,37,38)/t28-,31+/m1/s1 | Definition date: | 2020-12-23 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | ~{N}-[(2~{S})-4-cyclohexyl-1-[[(3~{R})-1-methylsulfonylpiperidin-3-yl]amino]-1-oxidanylidene-butan-2-yl]-4-[[(1-phenylpyrazolo[3,4-d]pyrimidin-4-yl)amino]methyl]benzamide |
|
![XFD XFD](https://data.pdbj.org/pdbjplus/data/cc/svg/XFD.svg) | XFD | Name: | 2-{3-[3-chloro-5-(cyclopropylmethoxy)phenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}benzonitrile | Formula: | C27 H20 Cl N3 O2 | SMILES: | c1(c(cccc1)C#N)C5=CN(c2cnccc2)C(C(c3cc(cc(c3)OCC4CC4)Cl)=C5)=O | InChi: | InChI=1S/C27H20ClN3O2/c28-22-10-20(11-24(13-22)33-17-18-7-8-18)26-12-21(25-6-2-1-4-19(25)14-29)16-31(27(26)32)23-5-3-9-30-15-23/h1-6,9-13,15-16,18H,7-8,17H2 | Definition date: | 2020-12-15 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | 2-{3-[3-chloro-5-(cyclopropylmethoxy)phenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}benzonitrile |
|
![TK5 TK5](https://data.pdbj.org/pdbjplus/data/cc/svg/TK5.svg) | TK5 | Name: | 5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-[[(3~{R})-1-methylsulfonylpiperidin-3-yl]amino]-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide | Formula: | C34 H45 N7 O5 S | SMILES: | C[S](=O)(=O)N1CCC[CH](C1)NC(=O)[CH](CCC2CCCCC2)NC(=O)c3ccc(CNC(=O)c4cnn(c4N)c5ccccc5)cc3 | InChi: | InChI=1S/C34H45N7O5S/c1-47(45,46)40-20-8-11-27(23-40)38-34(44)30(19-16-24-9-4-2-5-10-24)39-32(42)26-17-14-25(15-18-26)21-36-33(43)29-22-37-41(31(29)35)28-12-6-3-7-13-28/h3,6-7,12-15,17-18,22,24,27,30H,2,4-5,8-11,16,19-21,23,35H2,1H3,(H,36,43)(H,38,44)(H,39,42)/t27-,30+/m1/s1 | Definition date: | 2020-12-23 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | 5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-[[(3~{R})-1-methylsulfonylpiperidin-3-yl]amino]-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide |
|
![TKB TKB](https://data.pdbj.org/pdbjplus/data/cc/svg/TKB.svg) | TKB | Name: | 5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-[[(3~{R})-1-methylsulfonylpiperidin-3-yl]amino]-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-methyl-pyrazole-4-carboxamide | Formula: | C29 H43 N7 O5 S | SMILES: | Cn1ncc(C(=O)NCc2ccc(cc2)C(=O)N[CH](CCC3CCCCC3)C(=O)N[CH]4CCCN(C4)[S](C)(=O)=O)c1N | InChi: | InChI=1S/C29H43N7O5S/c1-35-26(30)24(18-32-35)28(38)31-17-21-10-13-22(14-11-21)27(37)34-25(15-12-20-7-4-3-5-8-20)29(39)33-23-9-6-16-36(19-23)42(2,40)41/h10-11,13-14,18,20,23,25H,3-9,12,15-17,19,30H2,1-2H3,(H,31,38)(H,33,39)(H,34,37)/t23-,25+/m1/s1 | Definition date: | 2020-12-23 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | 5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-[[(3~{R})-1-methylsulfonylpiperidin-3-yl]amino]-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-methyl-pyrazole-4-carboxamide |
|
![RXH RXH](https://data.pdbj.org/pdbjplus/data/cc/svg/RXH.svg) | RXH | Name: | Naproxen Methyl Ester | Formula: | C15 H16 O3 | SMILES: | COC(=O)[CH](C)c1ccc2cc(OC)ccc2c1 | InChi: | InChI=1S/C15H16O3/c1-10(15(16)18-3)11-4-5-13-9-14(17-2)7-6-12(13)8-11/h4-10H,1-3H3/t10-/m0/s1 | Synonyms: | Methyl (2S)-2-(6-methoxynaphthalen-2-yl)propanoate | Definition date: | 2020-10-29 | Last modified: | 2021-02-26 | Release date: | 2021-03-03 | Identifier: | methyl (2~{S})-2-(6-methoxynaphthalen-2-yl)propanoate |
|